Boulder Diagnostics launches Lyme test
Last Updated: 15:13 November 9, 2012
The Boulder-based company is offering its SpiroFind trademarked test as a diagnostic service from its clinical diagnostic service laboratory in Mellrichstadt, Germany. The test has received the European "CE" mark needed for commercial sale, meaning that it meets safety, health, environmental protection and other requirements.
"The SpiroFind test is the first method to query the trained immunity to Borrelia infection as a signal for active disease," Wolfgang Pieken, chief executive officer at Boulder Diagnostics, said in a statement.
In January, the company licensed the test from the University of Nijmegen in The Netherlands. Boulder Diagnostics plans to bring the product to the United States market in 2013, Pieken has said.
The company also does research on other diagnostic tests - one for liver damage from alcohol abuse and one trademarked as ParaFlor that can detect parasite infections in patients.
Privately held Boulder Diagnostics has funding from angel investors, Pieken has said.
More breaking news...
Tobacco retailer plans pot-accessory stores
The proposed legislation follows approval by the Internal Revenue Service
Open records act bill ready for governor's signature
State starts upgrade to system for Medicaid claims
House bill 1193, introduced by Rep. Joe Salazar, D-Thornton, and Sen. John Kefalas,
The current system, called the